Probiotic manufacturer, Blis Technologies, has reported a 10% increase in revenue for the third quarter ending on Dec 31 2023.
The company also achieved a positive earnings before interest, taxes, depreciation, and amortisation (EBITDA) result of $0.3 million.
The revenue growth was driven by a 12% rise in business-to-business (B2B) revenue, as well as stronger-than-expected performance in New Zealand and Amazon.
Blis attributed the positive outcomes to the successful execution of its refocused strategic plan, which included closer collaboration with business partners.
Based on the latest customer sales forecasts and market feedback, the company expects full-year revenue to be around $11m, marking a return to profitability.
See more
